Brief: SAB Biotherapeutics Provides Company Update And Reports Full Year 2021 Financial Results
29/03/2022 22:22
March 29 (Reuters) - SAB Biotherapeutics Inc SABS.O :
* SAB BIOTHERAPEUTICS PROVIDES COMPANY UPDATE AND REPORTS
FULL
YEAR 2021 FINANCIAL RESULTS
* SAB BIOTHERAPEUTICS INC - SUFFICIENT CASH AND GOVERNMENT
FUNDING
ANTICIPATED TO OPERATE THROUGH Q3 2023
Source text for Eikon: ID:nGNX7zbWJr
Further company coverage: SABS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SAB Biotherapeutics
See all newsSAB Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
SAB Biotherapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Ferrari, Hawkeye 360, Micron Technology
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies
U.S. STOCKS ON THE MOVE-InspireMD, MiniMed, SoFi Technologies